Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells beauty products worldwide. It operates through Prestige and Consumer Beauty segments. The company provides fragrance, color cosmetics, and skin and body care products. It offers Prestige segment products primarily through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under the Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Joop!, Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, philosophy, SKKN BY KIM, and Tiffany & Co. brands. The company provides Consumer Beauty segment products primarily through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, Beckham, Biocolor, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, and Sally Hansen brands. It also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York. Coty Inc. is a subsidiary of JAB Beauty B.V.
Stock data | 2023 | Change |
---|---|---|
Price | $9.38 | N/A |
Market Cap | $7.96B | N/A |
Shares Outstanding | 849.00M | 3.46% |
Employees | 11.35K | N/A |
Shareholder Equity | 4.23B | 18.98% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 16.46 | N/A |
P/S Ratio | 1.43 | N/A |
P/B Ratio | 1.88 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.1236 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $5.55B | N/A |
Earnings | $523.20M | N/A |
EPS | 0.57 | N/A |
Earnings Yield | 0.0608 | N/A |
Gross Margin | 0.6387 | N/A |
Operating Margin | 0.0967 | N/A |
Net income margin | 0.0942 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $12.66B | N/A |
Total Debt | $4.55B | N/A |
Cash on Hand | $246.90M | N/A |
Debt to Equity | $1.99 | -17.23% |
Cash to Debt | 0.0543 | 11.25% |
Current Ratio | 0.7497 | 14.36% |